You are using an older browser version. Please use a supported version for the best MSN experience.

Oxford/AstraZeneca Vaccine 'Highly Effective'

A third COVID-19 vaccine developed by the Univ. of Oxford and AstraZeneca showed an average of 70% efficacy based on interim analysis — both Moderna and Pfizer/BioNTech announced their vaccines were more than 90% efficacious earlier this month. For more coronavirus news and COVID-19 updates, subscribe to NowThis News. #COVID19 #AstraZeneca #News #NowThis #NowThisNews

Latest News Video

More News Video Partners

image beaconimage beaconimage beacon